Related Experiment Video
Updated: Jul 19, 2025

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Left ventricular assist device implantation combined with hemiarch replacement for severe aortic atherosclerosis
June Lee1, Seok Beom Hong1, Yong Han Kim1
1Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Insights
Left ventricular assist device (LVAD) implantation combined with aortic replacement successfully treated severe heart failure and aortic atherosclerosis in a patient, mitigating stroke risk. This combined approach offers a viable option for select patients.
Area of Science:
- Cardiovascular Surgery
- Medical Devices
- Heart Failure Management
Background:
- Left ventricular assist device (LVAD) implantation is a key therapy for severe heart failure.
- Stroke is a recognized complication following LVAD procedures.
- The safety and efficacy of combining LVAD implantation with aortic surgery for severe aortic atherosclerosis remain largely unexplored.
Purpose of the Study:
- To describe a novel surgical technique combining LVAD implantation with hemiarch replacement in a patient with severe aortic atherosclerosis.
- To assess the feasibility and safety of this combined approach in reducing perioperative stroke risk.
Main Methods:
- A 72-year-old male patient with advanced heart failure underwent HeartMate 3 LVAD implantation.
- Severe ascending aorta atherosclerosis necessitated hemiarch replacement using cardiopulmonary bypass, moderate hypothermia, and bilateral antegrade cerebral perfusion.
- Outflow graft anastomosis was performed to an artificial ascending aortic graft post-replacement.
Main Results:
- The combined LVAD implantation and hemiarch replacement procedure was successfully completed.
- The patient experienced no postoperative complications, including neurological deficits.
- This technique effectively managed both severe heart failure and severe aortic atherosclerosis.
Conclusions:
- LVAD implantation combined with aortic replacement is a potentially viable strategy for carefully selected patients.
- This approach can mitigate the risk of perioperative stroke in patients with severe aortic atherosclerosis undergoing LVAD implantation.
- Further research is warranted to validate this combined surgical approach in a broader patient population.
Abstract:
Implantation of the left ventricular assist device (LVAD) has emerged as a widely employed therapeutic approach for specifically chosen individuals suffering from severe heart failure. Stroke is a well-known complication of LVAD implantation. Concomitant aortic surgeries in patients requiring LVAD implantation to avoid outflow graft anastomosis to a severe atherosclerotic aorta are unknown. We illustrate a successful LVAD implantation with hemiarch replacement for severe aortic atherosclerosis to decrease the risk of postoperative stroke. A 72-year-old male patient with advanced heart failure has chosen to undergo LVAD treatment. Preoperative examinations detected severe atherosclerosis in the ascending aorta. It was determined that clamping the ascending aorta and directly connecting the outflow graft could increase the risk of stroke after surgery. Therefore, it was decided to replace the diseased ascending aorta entirely. The HeartMate 3 was implanted under cardiopulmonary bypass (CPB) using right axillary artery cannulation. And moderate hypothermia and bilateral antegrade cerebral perfusion were utilized to perform hemiarch replacement. Subsequently, the outflow graft was connected to an artificial ascending aortic graft. The patient did not exhibit any specific complications, such as neurological abnormalities, after the surgery. Based on our observations, it appears that LVAD implantation combined with aortic replacement could be a viable option for specific patients, particularly those who have a perioperative stroke risk due to aortic atherosclerosis.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Cardiomyopathy V: Interprofessional Care

